Wilfried Schgoer

1.5k total citations
31 papers, 894 citations indexed

About

Wilfried Schgoer is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Wilfried Schgoer has authored 31 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in Wilfried Schgoer's work include Cholesterol and Lipid Metabolism (8 papers), Lipoproteins and Cardiovascular Health (6 papers) and Angiogenesis and VEGF in Cancer (6 papers). Wilfried Schgoer is often cited by papers focused on Cholesterol and Lipid Metabolism (8 papers), Lipoproteins and Cardiovascular Health (6 papers) and Angiogenesis and VEGF in Cancer (6 papers). Wilfried Schgoer collaborates with scholars based in Austria, United States and Germany. Wilfried Schgoer's co-authors include Josef R. Patsch, Rudolf Kirchmair, Markus Theurl, Andreas Ritsch, Karin Albrecht-Schgoer, Ivan Tancevski, Kathrin Eller, Andreas Wehinger, Arno Beer and Ursula Stanzl and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Wilfried Schgoer

31 papers receiving 883 citations

Peers

Wilfried Schgoer
Kay M. Southgate United Kingdom
Rok Humar Switzerland
K. Graf Germany
El Houari Laghmani Netherlands
Panagiotis Flevaris United States
Simon Allen United Kingdom
Amy Mohan United States
Kay M. Southgate United Kingdom
Wilfried Schgoer
Citations per year, relative to Wilfried Schgoer Wilfried Schgoer (= 1×) peers Kay M. Southgate

Countries citing papers authored by Wilfried Schgoer

Since Specialization
Citations

This map shows the geographic impact of Wilfried Schgoer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilfried Schgoer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilfried Schgoer more than expected).

Fields of papers citing papers by Wilfried Schgoer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilfried Schgoer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilfried Schgoer. The network helps show where Wilfried Schgoer may publish in the future.

Co-authorship network of co-authors of Wilfried Schgoer

This figure shows the co-authorship network connecting the top 25 collaborators of Wilfried Schgoer. A scholar is included among the top collaborators of Wilfried Schgoer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilfried Schgoer. Wilfried Schgoer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albrecht-Schgoer, Karin, Jan Barthelmes, Wilfried Schgoer, et al.. (2017). Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model. Journal of Controlled Release. 250. 1–8. 24 indexed citations
2.
Hadzijusufovic, Emir, Karin Albrecht-Schgoer, K. Huber, et al.. (2017). Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site. Leukemia. 31(11). 2388–2397. 105 indexed citations
3.
Theurl, Markus, Wilfried Schgoer, Karin Albrecht-Schgoer, et al.. (2014). Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E−/− mice without influencing systemic atherosclerosis. Cardiovascular Research. 105(1). 96–106. 14 indexed citations
4.
Schgoer, Wilfried, Markus Theurl, Karin Albrecht-Schgoer, et al.. (2013). Secretoneurin Gene Therapy Improves Blood Flow in an Ischemia Model in Type 1 Diabetic Mice by Enhancing Therapeutic Neovascularization. PLoS ONE. 8(9). e74029–e74029. 17 indexed citations
5.
Albrecht-Schgoer, Karin, Wilfried Schgoer, Markus Theurl, et al.. (2013). Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGF. Angiogenesis. 17(1). 27–36. 20 indexed citations
6.
Albrecht-Schgoer, Karin, K. Huber, Florian Grebien, et al.. (2013). Nilotinib Exerts Direct Pro-Atherogenic and Anti-Angiogenic Effects On Vascular Endothelial Cells: A Potential Explanation For Drug-Induced Vasculopathy In CML. Blood. 122(21). 257–257. 43 indexed citations
7.
Tancevski, Ivan, Egon Demetz, Kathrin Eller, et al.. (2010). The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice. PLoS ONE. 5(1). e8722–e8722. 43 indexed citations
8.
Wehinger, Andreas, Ivan Tancevski, Sandra Frotschnig, et al.. (2009). Influence of aspirin on SR-BI expression in human carotid plaques. Atherosclerosis. 206(1). 234–238. 5 indexed citations
9.
Eller, Kathrin, Wilfried Schgoer, Thomas Mueller, et al.. (2008). The K121Q polymorphism of ENPP1 and peripheral arterial disease. Heart and Vessels. 23(2). 104–107. 6 indexed citations
10.
Egger, Margot, Arno Beer, Markus Theurl, et al.. (2008). Monocyte migration: A novel effect and signaling pathways of catestatin. European Journal of Pharmacology. 598(1-3). 104–111. 75 indexed citations
11.
Tancevski, Ivan, Andreas Wehinger, Egon Demetz, et al.. (2008). The thyromimetic T-0681 protects from atherosclerosis. Journal of Lipid Research. 50(5). 938–944. 29 indexed citations
12.
Schgoer, Wilfried, Kathrin Eller, Thomas Mueller, et al.. (2008). The MTP −493TT genotype is associated with peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) Study. Clinical Biochemistry. 41(9). 712–716. 10 indexed citations
13.
Ritsch, Andreas, A. Sandhofer, Ivan Tancevski, et al.. (2007). Scavenger receptor class B type I polymorphisms and peripheral arterial disease. Metabolism. 56(8). 1135–1141. 25 indexed citations
14.
Schgoer, Wilfried, Thomas Mueller, Matti Jauhiainen, et al.. (2007). Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. Atherosclerosis. 196(1). 219–226. 43 indexed citations
15.
Tancevski, Ivan, Andreas Wehinger, Egon Demetz, et al.. (2006). Hyperthyroidism decreases plasma HDL cholesterol by inhibition of hepatic ABCA1 expression. Data Archiving and Networked Services (DANS). 1 indexed citations
16.
Eller, Kathrin, Kathrin Hochegger, Andreas Wehinger, et al.. (2006). Hepatic ENPP1 expression is induced in diabetic rabbits. Mammalian Genome. 17(8). 886–891. 6 indexed citations
17.
Eller, Kathrin, Wilfried Schgoer, Thomas Mueller, et al.. (2005). Hepatic lipase polymorphism and increased risk of peripheral arterial disease. Journal of Internal Medicine. 258(4). 344–348. 28 indexed citations
18.
Tancevski, Ivan, Saša Frank, Petra Massoner, et al.. (2005). Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I. Journal of Molecular Medicine. 83(11). 927–932. 19 indexed citations
19.
Tancevski, Ivan, Andreas Wehinger, Wilfried Schgoer, et al.. (2005). W15-P-007 Influence of aspirin on expression and function of scavenger receptor-BI within primary human macrophages: A new atheroprotective mechanism of aspirin?. Atherosclerosis Supplements. 6(1). 98–98. 2 indexed citations
20.
Ritsch, Andreas, Christoph Ebenbichler, Elisabeth Naschberger, et al.. (2004). Phage-displayed recombinant single-chain antibody fragments with high affinity for cholesteryl ester transfer protein (CETP): cDNA cloning, characterization and CETP quantification. Clinical Chemistry and Laboratory Medicine (CCLM). 42(3). 247–55. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026